PE20120498A1 - Emulsiones nutritivas con un contenido elevado de fibras para controlar la glucosa en la sangre - Google Patents

Emulsiones nutritivas con un contenido elevado de fibras para controlar la glucosa en la sangre

Info

Publication number
PE20120498A1
PE20120498A1 PE2011001803A PE2011001803A PE20120498A1 PE 20120498 A1 PE20120498 A1 PE 20120498A1 PE 2011001803 A PE2011001803 A PE 2011001803A PE 2011001803 A PE2011001803 A PE 2011001803A PE 20120498 A1 PE20120498 A1 PE 20120498A1
Authority
PE
Peru
Prior art keywords
weight
blood
fiber content
high fiber
nutritional emulsions
Prior art date
Application number
PE2011001803A
Other languages
English (en)
Inventor
Neile K Edens
Vikkie A Mustad
Joseph E Walton
David R Wolf
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PE20120498A1 publication Critical patent/PE20120498A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pediatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Edible Oils And Fats (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

REFERIDA A UNA EMULSION ACUOSA QUE COMPRENDE GRASAS, PROTEINAS E HIDRATOS DE CARBONO Y QUE INCLUYE ENTRE 1,75% Y 4% EN PESO DE UN ACEITE DE DIACILGLICEROL, ENTRE 0,5% Y 9,0% EN PESO DE UN CONCENTRADO DE PROTEINAS DE LECHE, ENTRE 2,0% Y 9,0% EN PESO DE FIBRAS, FRUCTUOSA Y 0,15% DE LEUCROSA, DONDE LA PROPORCION EN PESO ENTRE FRUCTUOSA Y LEUCROSA ES DE 2:1. TAMBIEN PUEDE CONTENER DE 0,1% A 0,5% EN PESO DE LECITINA, PICOLINATO DE CROMO, CARRAGENANO Y TURMERICO. DICHA EMULSION ES UTIL PARA PACIENTES QUE PRESENTAN AFECCIONES CARACTERIZADAS POR UNA TOLERANCIA ANORMAL A LA GLUCOSA
PE2011001803A 2009-04-14 2010-04-13 Emulsiones nutritivas con un contenido elevado de fibras para controlar la glucosa en la sangre PE20120498A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16903009P 2009-04-14 2009-04-14

Publications (1)

Publication Number Publication Date
PE20120498A1 true PE20120498A1 (es) 2012-05-31

Family

ID=42245949

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011001803A PE20120498A1 (es) 2009-04-14 2010-04-13 Emulsiones nutritivas con un contenido elevado de fibras para controlar la glucosa en la sangre

Country Status (14)

Country Link
EP (1) EP2418972A1 (es)
JP (1) JP2012523840A (es)
CN (1) CN102740713A (es)
AU (1) AU2010236680A1 (es)
BR (1) BRPI1011465A2 (es)
CA (1) CA2758854A1 (es)
CO (1) CO6450646A2 (es)
EC (1) ECSP11011397A (es)
IL (1) IL215595A0 (es)
MX (1) MX2011010925A (es)
PE (1) PE20120498A1 (es)
RU (1) RU2011141531A (es)
SG (1) SG175193A1 (es)
WO (1) WO2010120736A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102481010A (zh) * 2009-04-14 2012-05-30 雅培制药有限公司 高纤维营养乳剂
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
WO2016069475A1 (en) 2014-10-27 2016-05-06 Aseko, Inc. Subcutaneous outpatient management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
AU2016308953B2 (en) 2015-08-20 2020-09-10 Glytec, Llc Diabetes management therapy advisor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
US20040209953A1 (en) * 2002-12-06 2004-10-21 Wai Lee Theresa Siu-Ling Glyceride compositions and methods of making and using same
ATE508648T1 (de) * 2003-07-15 2011-05-15 Nestec Sa Kalorien- und faserstoffreiche flüssige nahrungszusammensetzung für die darmgesundheit älterer patienten
AU2006331845A1 (en) * 2005-12-21 2007-07-05 Abbott Laboratories Induced-viscosity nutritional emulsions
WO2008140064A1 (ja) * 2007-05-07 2008-11-20 Bbk Bio Corporation 生活習慣病の予防および改善のための栄養組成物

Also Published As

Publication number Publication date
JP2012523840A (ja) 2012-10-11
IL215595A0 (en) 2011-12-29
SG175193A1 (en) 2011-11-28
CN102740713A (zh) 2012-10-17
WO2010120736A1 (en) 2010-10-21
CA2758854A1 (en) 2010-10-21
ECSP11011397A (es) 2011-11-30
MX2011010925A (es) 2012-01-19
BRPI1011465A2 (pt) 2015-08-25
EP2418972A1 (en) 2012-02-22
AU2010236680A1 (en) 2011-11-10
CO6450646A2 (es) 2012-05-31
RU2011141531A (ru) 2013-05-20

Similar Documents

Publication Publication Date Title
PE20120498A1 (es) Emulsiones nutritivas con un contenido elevado de fibras para controlar la glucosa en la sangre
PE20121726A1 (es) Emulsiones nutricionales que comprenden beta-hidroxi-beta-metilbutirato (hmb) de calcio y proteina soluble
BR112016010422A8 (pt) suplemento dietético, e uso de uma composição
PE20142168A1 (es) Composicion y metodo para el diagnostico y el tratamiento de las enfermedades asociadas a la degeneracion de las neuritas
BR112017008161A2 (pt) método para preparação de uma composição de lisolecitina, composição de lisolecitina, emulsão flavorizante, e, bebida líquida ou concentrado de bebida líquida.
DOP2013000299A (es) Anticuerpos anti-angptl3 y usos de los mismos
BR112014016887A2 (pt) potencialização do transporte de moléculas terapêu-ticas através da barreira hematoencefálica
BR112013028474A2 (pt) extrator de tendão do quadríceps
BR112017017840A2 (pt) composição compreendendo sialil-lactose para uso na melhora das capacidades de aprendizado e função de memória
MX2009009839A (es) Formulaciones farmaceuticas a base de lipidos apolares y polares para uso oftalmico.
PE20120880A1 (es) Emulsiones nutritivas con un contenido elevado de fibras
Dalmases et al. Brain tissue hypoxia and oxidative stress induced by obstructive apneas is different in young and aged rats
BR112012029470A8 (pt) Emulsões nutricionais contendo óleos encapsulados em processo
PE20120558A1 (es) Emulsiones nutritivas con un contenido elevado de fibras que comprenden glicerina
BR112012000639B8 (pt) dispositivo médico implantável para lubrificação de uma articulação sinovial
Yang et al. Salt restriction leads to activation of adult renal mesenchymal stromal cell–like cells via prostaglandin E2 and E-prostanoid receptor 4
BR112013005575A2 (pt) líquidos laticínios concentrados com alto teor de sólidos
CO7101225A2 (es) Enriquecimiento de fluidos de yacimientos de petróleo con shewanella
Reid Redox implications of extreme task performance: the case in driver athletes
BR112015000929A2 (pt) método para separar uma emulsão de óleo em água
Deryabina On Actual Methodical Research Areas in Russian as a Foreign Language (Based on Dissertation Papers Defended at the Chair of the Russian Language and Methods of Its Teaching)
José Building Bridges Between Cultural Studies and Translation Studies: With Reference to the Audiovisual Field
Kovtunenko et al. III International Congress “National Identity through the Prism of the Dialogue of Cultures: Russia and the Ibero-American World”
Gorham Daniela S. Hristova (1962-2010)
Culik Subject content optimization of textbooks oriented for first-yearstudents of russian as a foreign language as well as for learners studyingat preparatory course

Legal Events

Date Code Title Description
FA Abandonment or withdrawal